Evidence map›Paper›PMID 36113568›Full record

ArticleCryobiology2022

Multiple cryoprotectant toxicity model for vitrification solution optimization.

Ross M Warner, Kevin S Brown, James D Benson, Ali Eroglu, Adam Z Higgins

Abstract read
In one paragraph

Article in Cryobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Thermodynamic Principles of Emerging Cryopreservation Technologies.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  4. How Early-Life Programming During Embryogenesis Imprints Cellular Memory.International journal of molecular sciences · 2025
    Review
  5. Article
  6. A size-dependent ideal solution model for liquid-solid phase equilibria prediction in aqueous organic solutions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ross M WarnerSchool of Chemical, Biological and Environmental Engineering, Oregon State University, Corvallis, OR, USA.
Kevin S BrownSchool of Chemical, Biological and Environmental Engineering, Oregon State University, Corvallis, OR, USA; College of Pharmacy, Oregon State University, Corvallis, OR, USA.
James D BensonDepartment of Biology, University of Saskatchewan, Saskatoon, SK, Canada.
Ali ErogluDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia - Augusta University, Augusta, GA, USA.
Adam Z HigginsSchool of Chemical, Biological and Environmental Engineering, Oregon State University, Corvallis, OR, USA. Electronic address: adam.higgins@oregonstate.edu.

Funding

Viable Banking of Human TissuesR01EB027203 · NIBIB · AUGUSTA UNIVERSITY · PI EROGLU, ALI · 2018 to 2021
$1.5M
NIBIB NIH HHS R01 EB027203
6 · The paper itself

Abstract

Vitrification is a promising cryopreservation technique for complex specimens such as tissues and organs. However, it is challenging to identify mixtures of cryoprotectants (CPAs) that prevent ice formation without exerting excessive toxicity. In this work, we developed a multi-CPA toxicity model that predicts the toxicity kinetics of mixtures containing five of the most common CPAs used in the field (glycerol, dimethyl sulfoxide (DMSO), propylene glycol, ethylene glycol, and formamide). The model accounts for specific toxicity, non-specific toxicity, and interactions between CPAs. The proposed model shows reasonable agreement with training data for single and binary CPA solutions, as well as ternary CPA solution validation data. Sloppy model analysis was used to examine the model parameters that were most important for predictions, providing clues about mechanisms of toxicity. This analysis revealed that the model terms for non-specific toxicity were particularly important, especially the non-specific toxicity of propylene glycol, as well as model terms for specific toxicity of formamide and interactions between formamide and glycerol. To demonstrate the potential for model-based design of vitrification methods, we paired the multi-CPA toxicity model with a published vitrification/devitrification model to identify vitrifiable CPA mixtures that are predicted to have minimal toxicity. The resulting optimized vitrification solution composition was a mixture of 7.4 molal glycerol, 1.4 molal DMSO, and 2.4 molal formamide. This demonstrates the potential for mathematical optimization of vitrification solution composition and sets the stage for future studies to optimize the complete vitrification process, including CPA mixture composition and CPA addition and removal methods.

Indexed as

Dimethyl SulfoxideVitrificationCryopreservationCryoprotective AgentsEthylene GlycolFormamidesGlycerolIcePropylene GlycolCryoprotective AgentsDimethyl SulfoxideEthylene GlycolformamideFormamidesGlycerolIcePropylene GlycolCryopreservationCryoprotectantsOptimizationSloppy modelsToxicityVitrification

Identifiers

PMID36113568
PMCPMC9529850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.